Cardiovascular Drugs Practice Questions

Q: Verapamil belongs to which class of antiarrhythmic drugs?

Class IV. ***Class IV*** Verapamil is a calcium channel blocker that primarily works by inhibiting L-type calcium channels [1]. Class IV antiarrhythmics, like verapamil and diltiazem, are used to slow conduction through the AV node and reduce heart rate, particularly in supraventricular tachycardias [1, 2]. *Class I* Class I antiarrhythmics are sodium channel blockers [2] that primarily affect the fast depolarization phase of the action potential in cardiac myocytes. These are further subdivided into Ia, Ib, and Ic based on their effects on repolarization and binding kinetics. *Class II* Class II antiarrhythmics are beta-blockers (e.g., propranolol, metoprolol) that reduce sympathetic activity on the heart. They primarily act by blocking beta-adrenergic receptors, leading to decreased heart rate and contractility. *Class III* Class III antiarrhythmics are potassium channel blockers that prolong repolarization and the effective refractory period. Examples include amiodarone, sotalol, and dofetilide.

Q: Which medication is primarily used for chemical cardioversion in patients with atrial fibrillation?

Amiodarone. ***Amiodarone*** - **Amiodarone** is a Class III antiarrhythmic agent effective for both rate and rhythm control in **atrial fibrillation**, commonly used for **chemical cardioversion**. - It works by blocking potassium channels, prolonging the **action potential duration** and **QT interval**, thereby restoring normal sinus rhythm. *Digoxin* - **Digoxin** is primarily used for **rate control** in atrial fibrillation, particularly in patients with heart failure or left ventricular dysfunction. - It does not effectively **cardiovert** the rhythm to sinus rhythm but rather slows the ventricular response. *Metoprolol* - **Metoprolol** is a **beta-blocker** primarily used for **rate control** in atrial fibrillation by slowing conduction through the AV node. - While it helps manage heart rate, it is not a first-line agent for **chemical cardioversion** to restore sinus rhythm. *Diltiazem* - **Diltiazem** is a **non-dihydropyridine calcium channel blocker** used for **rate control** in atrial fibrillation by blocking the AV nodal conduction. - Similar to metoprolol and digoxin, its main role is to control ventricular rate, not to **chemically cardiovert** to sinus rhythm.

Q: A 50-year-old man with a history of coronary artery disease presents with chest pain radiating to the left arm. Which drug is most likely to relieve his symptoms?

Nitrates. ***Nitrates*** - **Nitrates** (e.g., nitroglycerin) cause **vasodilation**, particularly of the coronary arteries, which increases blood flow to the ischemic myocardium and reduces **preload** and **afterload**, thereby alleviating chest pain. - They are a rapid and effective treatment for acute angina symptoms, making them the most likely drug to provide immediate relief in this scenario. *Clopidogrel* - **Clopidogrel** is an antiplatelet medication that inhibits platelet aggregation by blocking the **ADP receptor** on platelets, preventing thrombus formation. - While important in long-term management of coronary artery disease, it does not directly relieve acute chest pain caused by myocardial ischemia. *Beta-blockers* - **Beta-blockers** reduce myocardial oxygen demand by decreasing heart rate, contractility, and blood pressure. - They are used for chronic management and prevention of angina but are not typically the first-line treatment for immediate relief of acute chest pain, as their onset of action is slower than nitrates. *Aspirin* - **Aspirin** is an antiplatelet drug that inhibits **cyclooxygenase (COX) enzymes**, reducing the production of thromboxane A2, thereby preventing platelet aggregation. - It is crucial in acute coronary syndromes to prevent clot formation and reduce mortality, but it does not directly alleviate the anginal chest pain itself.

Q: Which of the following is a common side effect of angiotensin-converting enzyme (ACE) inhibitors?

Dry cough. ***Dry cough*** - This is a well-known side effect of ACE inhibitors, occurring in up to 20% of patients. It is thought to be caused by the accumulation of **bradykinin** and **substance P** in the respiratory tract, as ACE is responsible for their degradation. - The cough is typically non-productive, persistent, and resolves upon discontinuation of the medication. *Bradycardia* - **Bradycardia**, or a slow heart rate, is not a common side effect of ACE inhibitors. - ACE inhibitors primarily work by reducing systemic vascular resistance and blood pressure, with minimal direct effect on heart rate. *Hypoglycemia* - **Hypoglycemia**, or low blood sugar, is not typically associated with ACE inhibitor use. - While some medications can affect glucose metabolism, ACE inhibitors do not directly cause hypoglycemia. *Constipation* - **Constipation** is not a common side effect of ACE inhibitors. - Gastrointestinal side effects are generally mild and less frequent with ACE inhibitors compared to some other drug classes.

Q: What is the primary mechanism of action of digoxin in the treatment of heart failure?

Inhibition of Na+/K+ ATPase. ***Inhibition of Na+/K+ ATPase*** - Digoxin directly inhibits the **sodium-potassium ATPase pump** in cardiac muscle cells, leading to an increase in intracellular sodium. - This increase in intracellular sodium then reduces the activity of the **sodium-calcium exchanger**, resulting in higher intracellular calcium levels and increased myocardial contractility (positive inotropy). *Inhibition of angiotensin II receptor* - This is the mechanism of action for **angiotensin receptor blockers (ARBs)**, which are used in heart failure to reduce vasoconstriction and aldosterone release. - Digoxin does not directly interact with the **renin-angiotensin-aldosterone system** at the receptor level. *Inhibition of aldosterone secretion* - Aldosterone secretion is primarily inhibited by medications like **ACE inhibitors** and **ARBs**, or directly by aldosterone antagonists such as spironolactone. - Digoxin does not have a direct effect on the **adrenal gland's production** of aldosterone. *Inhibition of beta-adrenergic receptors* - This is the primary mechanism of action of **beta-blockers**, which are used in heart failure to reduce heart rate, myocardial oxygen demand, and remodeling. - Digoxin has a **positive inotropic effect** and does not block beta-adrenergic receptors; in fact, it can have some vagomimetic effects that slow heart rate.

Q: Which adrenergic receptor subtype is targeted by beta-blockers like propranolol to lower blood pressure and manage angina?

Beta-1. ***Beta-1*** - **Beta-1 adrenergic receptors** are primarily located in the **heart**, and their blockade leads to decreased heart rate, contractility, and ultimately, lower blood pressure and reduced myocardial oxygen demand in angina [1], [2]. - While propranolol is a non-selective beta-blocker, its cardiovascular therapeutic effects are predominantly mediated through **beta-1 receptor blockade** in the heart [2]. *Alpha-1* - **Alpha-1 adrenergic receptors** are found in **vascular smooth muscle** and mediate **vasoconstriction** when activated. - Blocking these receptors, as with prazosin, would cause **vasodilation** and a drop in blood pressure, but this is not the primary mechanism of action for propranolol [2]. *Alpha-2* - **Alpha-2 adrenergic receptors** are typically located presynaptically, where they inhibit **norepinephrine release**, and centrally, where they can reduce sympathetic outflow. - Drugs like clonidine target these receptors to lower blood pressure, which is a mechanism distinct from beta-blockers. *Beta-2* - **Beta-2 adrenergic receptors** are predominantly found in **bronchial smooth muscle** and **vascular smooth muscle**, mediating bronchodilation and vasodilation, respectively. - Blocking these receptors, as a non-selective beta-blocker like propranolol does, can lead to adverse effects like **bronchoconstriction** in asthmatic patients, but it is not the primary target for lowering blood pressure or treating angina.

Q: Which of the following enzymes is inhibited by statins to lower cholesterol levels?

HMG-CoA reductase. ***HMG-CoA reductase*** * Statins (HMG-CoA reductase inhibitors) competitively block this enzyme, which is the **rate-limiting step** in cholesterol biosynthesis in the liver. * By inhibiting HMG-CoA reductase, statins reduce the synthesis of **mevalonate** and subsequently cholesterol, leading to a decrease in circulating LDL-C. *Acetyl-CoA carboxylase* * This enzyme is involved in **fatty acid synthesis**, not cholesterol synthesis. * It catalyzes the carboxylation of **acetyl-CoA to malonyl-CoA**, a key step in fatty acid elongation. *Fatty acid synthase* * This is a multienzyme complex responsible for the **synthesis of long-chain fatty acids** from acetyl-CoA and malonyl-CoA. * It plays no direct role in the synthesis of cholesterol. *Citrate lyase* * This enzyme is involved in the **synthesis of acetyl-CoA** from citrate in the cytoplasm, which can then be used for fatty acid or cholesterol synthesis. * While it provides a precursor for cholesterol, it is **not the direct rate-limiting step** targeted by statins.

Q: What are the effects of niacin on HDL and triglycerides in the management of familial combined hyperlipidemia?

Increases HDL; lowers triglycerides. Correct: Increases HDL; lowers triglycerides - Niacin (nicotinic acid) is known for its efficacy in significantly **raising high-density lipoprotein (HDL)** levels, typically by 15-35% [1]. - It also has a potent effect on **reducing triglyceride** levels by 20-50%, making it beneficial in dyslipidemias where both are deranged [1]. - This dual action makes niacin particularly useful in familial combined hyperlipidemia [2]. Incorrect: Decreases HDL; raises triglycerides - This option describes effects that are the opposite of niacin's known pharmacological actions on lipid profiles. - Niacin is clinically used to improve, not worsen, these lipid parameters. Incorrect: No significant effect on HDL; minor effect on triglycerides - This statement underestimates niacin's impact, as its primary clinical utility is derived from its substantial effects on both HDL increase and triglyceride reduction [1]. - Although it has varied effects, its impact is far from minor or insignificant on these lipid components. Incorrect: Increases both HDL and triglycerides - While niacin raises HDL, it consistently **lowers triglycerides**, particularly in conditions like familial combined hyperlipidemia where triglyceride elevation is a key feature [2]. - Therefore, the claim that it increases both is incorrect due to its opposite effect on triglycerides.

Q: Which antihypertensive drug is known for blocking the angiotensin II receptor (AT1) and reducing vasoconstriction?

Losartan. ***Losartan*** - Losartan is an **angiotensin receptor blocker (ARB)**, specifically blocking the **AT1 receptor** to prevent angiotensin II from binding. - This action leads to **vasodilation**, reduced aldosterone secretion, and decreased blood pressure, without the cough side effect associated with ACE inhibitors. *Amlodipine* - Amlodipine is a **calcium channel blocker** that primarily causes **vasodilation** by relaxing vascular smooth muscle. - Its mechanism involves inhibiting the influx of calcium ions into vascular smooth muscle cells, not blocking angiotensin II receptors. *Hydralazine* - Hydralazine is a **direct arterial vasodilator** that acts to relax smooth muscle in the arterioles. - Its mechanism of action is not related to the renin-angiotensin-aldosterone system (RAAS) but rather to directly reducing peripheral vascular resistance. *Propranolol* - Propranolol is a **non-selective beta-blocker** that reduces blood pressure by decreasing heart rate, myocardial contractility, and renin release. - It does not directly block angiotensin II receptors but can indirectly affect the RAAS by reducing renin secretion.

Q: Which antihypertensive medication is contraindicated in pregnancy due to its potential to cause fetal renal damage?

ACE inhibitors. ***ACE inhibitors*** - ACE inhibitors are **contraindicated in pregnancy (FDA Category D)** and can cause severe fetal renal damage, including **oligohydramnios**, **renal dysplasia**, and **anuria**, particularly when used in the second and third trimesters. - They inhibit fetal angiotensin II production, which is crucial for normal renal development and function. - **ARBs (Angiotensin Receptor Blockers)** share the same contraindication and risks. *Labetalol* - **Labetalol** is a **beta-blocker** commonly used to manage hypertension in pregnancy and is generally considered safe. - It does not have known associations with fetal renal damage. *Nifedipine* - **Nifedipine**, a **calcium channel blocker**, is another preferred agent for treating hypertension in pregnant women. - It is not contraindicated and is not associated with teratogenic effects on the fetal kidneys. *Methyldopa* - **Methyldopa** is often considered the **first-line antihypertensive** for chronic hypertension in pregnancy due to its long-standing safety record. - It works as a centrally acting alpha-agonist and does not cause fetal renal damage.

Question 1

Verapamil belongs to which class of antiarrhythmic drugs?

Accepted Answer

Class IV

Answer

Class I

Answer

Class II

Answer

Class III

Question 2

Which medication is primarily used for chemical cardioversion in patients with atrial fibrillation?

Accepted Answer

Amiodarone

Answer

Digoxin

Answer

Metoprolol

Answer

Diltiazem

Question 3

A 50-year-old man with a history of coronary artery disease presents with chest pain radiating to the left arm. Which drug is most likely to relieve his symptoms?

Accepted Answer

Nitrates

Answer

Beta-blockers

Answer

Clopidogrel

Answer

Aspirin

Question 4

Which of the following is a common side effect of angiotensin-converting enzyme (ACE) inhibitors?

Accepted Answer

Dry cough

Answer

Bradycardia

Answer

Hypoglycemia

Answer

Constipation

Question 5

What is the primary mechanism of action of digoxin in the treatment of heart failure?

Accepted Answer

Inhibition of Na+/K+ ATPase

Answer

Inhibition of angiotensin II receptor

Answer

Inhibition of aldosterone secretion

Answer

Inhibition of beta-adrenergic receptors

Question 6

Which adrenergic receptor subtype is targeted by beta-blockers like propranolol to lower blood pressure and manage angina?

Accepted Answer

Beta-1

Answer

Alpha-1

Answer

Alpha-2

Answer

Beta-2

Question 7

Which of the following enzymes is inhibited by statins to lower cholesterol levels?

Accepted Answer

HMG-CoA reductase

Answer

Acetyl-CoA carboxylase

Answer

Fatty acid synthase

Answer

Citrate lyase

Question 8

What are the effects of niacin on HDL and triglycerides in the management of familial combined hyperlipidemia?

Accepted Answer

Increases HDL; lowers triglycerides

Answer

Decreases HDL; raises triglycerides

Answer

No significant effect on HDL; minor effect on triglycerides

Answer

Increases both HDL and triglycerides

Question 9

Which antihypertensive drug is known for blocking the angiotensin II receptor (AT1) and reducing vasoconstriction?

Accepted Answer

Losartan

Answer

Amlodipine

Answer

Hydralazine

Answer

Propranolol

Question 10

Which antihypertensive medication is contraindicated in pregnancy due to its potential to cause fetal renal damage?

Accepted Answer

ACE inhibitors

Answer

Labetalol

Answer

Nifedipine

Answer

Methyldopa

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?